FUTURE WEBINAR - 2025, Tuesday May 13th - “AI Predictive Modelling for Drug Development”
CLICK HERE TO REGISTER
Bio: Luca Emili
Luca Emili is an entrepreneur and investor, founder and current CEO of InSilicoTrials Technologies, the first global platform that makes easy-to-use modeling and simulation to accelerate the pace of innovation in the healthcare and life science industry. From 2001 to 2010 he was CEO of Emaze, a cybersecurity company that became one of the market leaders in Italy by automating security analysis for complex networks and devices. He is a member of the Cloud Security Consultative Group in EMA and is responsible for the RCA Research Collaboration Agreement between InSilicoTrials and the FDA. He also co-chairs the Good Simulation Practice (GSP) Task Force within the Avicenna Alliance's Policy Development Working Group, with the goal of driving a consensus approach toward standardization for reliable development and use of in silico solutions.
